Synthesis, characterization, controlled release, and antibacterial studies of a novel streptomycin chitosan magnetic nanoantibiotic.
about
Chemical functionalization of bone implants with nanoparticle-stabilized chitosan and methotrexate for inhibiting both osteoclastoma formation and bacterial infectionVancomycin-modified Fe3O4@SiO2@Ag microflowers as effective antimicrobial agents.Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13.The ability of streptomycin-loaded chitosan-coated magnetic nanocomposites to possess antimicrobial and antituberculosis activitiesAntifungal activity of berberine hydrochloride and palmatine hydrochloride against Microsporum canis -induced dermatitis in rabbits and underlying mechanism.Bactericidal activity and biocompatibility of ceragenin-coated magnetic nanoparticles.Core-shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins.Sustained release of anticancer agent phytic acid from its chitosan-coated magnetic nanoparticles for drug-delivery systemUse of magnetic nanoparticles as a drug delivery system to improve chlorhexidine antimicrobial activity.Chemically Surface Tunable Solubility Parameter for Controllable Drug Delivery-An Example and Perspective from Hollow PAA-Coated Magnetite Nanoparticles with R6G Model Drug.Emerging Nanomedicine Therapies to Counter the Rise of Methicillin-Resistant Staphylococcus aureus.Bactericidal and immunomodulatory properties of magnetic nanoparticles functionalized by 1,4-dihydropyridines.Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity.Effect of Surface Charge and Hydrophobicity Modulation on the Antibacterial and Antibiofilm Potential of Magnetic Iron Nanoparticles
P2860
Q30402377-FB5D46FE-808C-4AE4-B211-BF4492871A8FQ33589402-04D07661-21CB-4D9B-A1CA-2EEC9433C3C8Q33870762-F97DA63B-CD72-447A-A828-22AFE98DEC3DQ35586465-438B8655-99C7-450C-816A-C65695E13EF1Q35657228-26E21D2B-3089-48F8-AE88-95DA1FD62D70Q35689986-6431F527-9F38-4237-966D-09288292B4B9Q37361845-6743761D-50E0-4A01-9FF1-98DB0A1CB065Q38708384-21662D49-CD90-42E4-A54C-EAFBF4415D60Q44787383-D4E3D77B-29E2-4172-832A-E57FC439F19BQ50131999-7A983568-08F3-43A3-8F6C-5DE1A631A53FQ50145801-60505411-BC01-4A2C-987E-A7811E959B08Q55195803-A1B7E969-4339-4B1B-87B3-48512D97B170Q55384208-CC5E6C26-189C-4E1C-B82E-4A83173AA86CQ57380405-50744A64-9356-4764-A151-ED8382403707
P2860
Synthesis, characterization, controlled release, and antibacterial studies of a novel streptomycin chitosan magnetic nanoantibiotic.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Synthesis, characterization, c ...... tosan magnetic nanoantibiotic.
@en
Synthesis, characterization, c ...... tosan magnetic nanoantibiotic.
@nl
type
label
Synthesis, characterization, c ...... tosan magnetic nanoantibiotic.
@en
Synthesis, characterization, c ...... tosan magnetic nanoantibiotic.
@nl
prefLabel
Synthesis, characterization, c ...... tosan magnetic nanoantibiotic.
@en
Synthesis, characterization, c ...... tosan magnetic nanoantibiotic.
@nl
P2093
P2860
P356
P1476
Synthesis, characterization, c ...... tosan magnetic nanoantibiotic.
@en
P2093
Mohd Zobir Hussein
Samer Hasan Hussein-Al-Ali
Thomas J Webster
P2860
P304
P356
10.2147/IJN.S53079
P407
P577
2014-01-16T00:00:00Z